R128126,R128127,R128129,R130126,R130127,R130129,R131126,R131127,R131129,id...10,accession_number,geneSymbol,numColumnsProteinObserved,numSpectraProteinObserved,numPepsUnique,numPepsUniqueSubgroupSpecificCI,accession_numbers,species,protein_mw,percentCoverage,groupNum,subgroupNum,scoreUnique,scoreUniqueSubgroupSpecificCI,orfCategory,sequenceLength,entry_name,cellular_component,biological_process,molecular_function,Liver_Searched.unique_peptides,Liver_Searched.numSpectra,Liver_Searched.totalIntensity,Liver_Searched.pct_cov,id...35,adj.P.Val.xBirA.over.NoBirA,AveExpr.xBirA.over.NoBirA,Log.P.Value.xBirA.over.NoBirA,logFC.xBirA.over.NoBirA,P.Value.xBirA.over.NoBirA,t.xBirA.over.NoBirA,Liver_Searched..126.126.127.128.129.130.131..No_BirA_4.multimedian,Liver_Searched..127.126.127.128.129.130.131..No_BirA_5.multimedian,Liver_Searched..129.126.127.128.129.130.131..No_BirA_6.multimedian,Liver_Searched..128.126.127.128.129.130.131..XBirA_2.multimedian,Liver_Searched..130.126.127.128.129.130.131..XBirA_3.multimedian,Liver_Searched..131.126.127.128.129.130.131..XBirA_1.multimedian,PCorNC,ES_score,signalP,TM
1.1935,0.215,1.631,0.468,-0.55,0.967,1.1565,0.1535,1.7075,E9QPE7,E9QPE7,Myh11,1,50,234,13,E9QPE7,MOUSE,224209.2,76.9,1,1.2,3358.94,219.28,NA,1938,Myosin-11,myosin complex|extracellular exosome|,metabolic process|elastic fiber assembly|cardiac muscle fiber development|regulation of mitochondrion degradation|,motor activity|actin binding|ATP binding|structural constituent of muscle|,13,50,3.54E+10,0.056,E9QPE7,0.391290592,-0.211166667,9.9092272,0.837,0.102112117,1.902798051,-0.744,0.279,-1.424,0.459,-0.286,0.449,undefined,6,NA,NA
0.3265,-0.293,0.612,0.369,-0.419,0.631,0.5525,0.1105,0.8955,O08638,O08638,Myh11,1,20,222,7,O08638,MOUSE,227879.9,73.1,1,1.3,3111.83,91.01,NA,1972,Myosin-11,stress fiber|muscle myosin complex|brush border|myosin complex|myofibril|smooth muscle contractile fiber|myosin filament|melanosome|extracellular exosome|,smooth muscle contraction|metabolic process|skeletal muscle myosin thick filament assembly|elastic fiber assembly|cardiac muscle fiber development|activation of mitophagy in response to mitochondrial depolarization|,motor activity|actin binding|calmodulin binding|ATP binding|structural constituent of muscle|,7,20,8.62E+09,0.024,O08638,0.453208977,-0.101666667,8.298805291,0.429333333,0.147951534,1.642143604,-0.35,0.198,-0.797,0.104,-0.128,0.363,undefined,6,NA,NA
0.9845,1.146,0.378,1.125,1.311,0.538,0.7975,0.9985,0.2265,Q8VHX6,Q8VHX6,Flnc,1,4,11,2,Q8VHX6|Q8VHX6-2,MOUSE,293738.4,4.3,14,14.3,135.64,9.4,NA,2726,Filamin-C,cytoplasm|plasma membrane|focal adhesion|actin cytoskeleton|Z disc|sarcolemma|,actin filament-based process|muscle fiber development|,actin binding|cytoskeletal protein binding|ankyrin binding|actin filament binding|,2,4,2.25E+08,0.009,Q8VHX6,0.059846217,-0.103833333,22.72351998,0.807666667,0.005341313,4.106615769,-0.645,-0.794,-0.084,0.286,0.462,0.152,NC,6,NA,NA
1.0445,0.926,1.764,1.591,1.351,2.046,1.4605,1.3425,2.1745,P23953,P23953,Ces1c,1,12,10,6,P23953,MOUSE,61339.9,24.1,56,56.3,130.68,71.66,NA,554,Carboxylesterase 1C,extracellular space|endoplasmic reticulum lumen|,metabolic process|,"hydrolase activity, acting on ester bonds|carboxylic ester hydrolase activity|",6,12,2.18E+09,0.182,P23953,0.02179321,-0.150166667,28.03561492,1.587,0.001571949,5.20961764,-0.68,-0.524,-1.627,0.335,0.798,0.797,PC,9,TRUE,NA
0.6095,1.143,1.883,-0.186,0.459,1.266,0.2515,0.8845,1.7305,P15392,P15392,Cyp2a4,1,41,42,13,P15392,MOUSE,56894.9,66.1,78,78.3,584.57,163.4,NA,494,Cytochrome P450 2A4,endoplasmic reticulum membrane|,response to stilbenoid|oxidation-reduction process|,iron ion binding|heme binding|aromatase activity|,13,41,2.91E+10,0.242,P15392,0.332207936,-0.175,11.46351498,0.922,0.071391828,2.152979477,0.119,-0.441,-1.586,0.563,-0.088,0.383,undefined,6,NA,TRUE
-0.0525,0.504,1.132,0.197,0.541,1.3,-0.4295,0.1585,0.8265,B2RXZ2,B2RXZ2,Cyp2a22,1,29,34,10,B2RXZ2,MOUSE,56488.6,60.9,78,78.4,454.68,110.39,NA,492,Cyp2a22 protein,cytoplasm|intracellular membrane-bounded organelle|,xenobiotic metabolic process|coumarin metabolic process|epoxygenase P450 pathway|exogenous drug catabolic process|oxidation-reduction process|,"iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|",10,29,1.13E+10,0.247,B2RXZ2,0.519555499,-0.118333333,6.953616965,0.450666667,0.201668609,1.42062127,0.204,-0.169,-1.066,0.103,0.308,-0.09,undefined,5,NA,TRUE
1.2585,1.177,1.033,0.984,0.913,0.809,1.4695,1.3755,1.2815,P28666,P28666,Mug2,1,137,47,23,P28666|A0A0N4SVU1,MOUSE,163805.4,40.7,117,117.1,616.99,305.99,NA,1451,Murinoglobulin-2,extracellular space|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,49,137,5.10E+10,0.407,P28666,0.001474261,-0.012833333,41.98550149,1.097666667,6.33E-05,9.089633485,-0.636,-0.56,-0.489,0.51,0.346,0.752,PC,9,TRUE,NA
1.0695,0.994,1.545,1.392,1.415,1.777,1.2365,1.1515,1.6055,P28665,P28665,Mug1,1,47,46,20,P28665,MOUSE,166721,41.5,117,117.2,614.63,289.56,NA,1476,Murinoglobulin-1,extracellular space|,embryo implantation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,20,47,1.66E+10,0.221,P28665,0.011171049,-0.1455,31.59329601,1.404333333,0.0006929,6.04588323,-0.633,-0.543,-1.367,0.382,0.751,0.537,PC,9,TRUE,NA
1.6885,1.573,1.919,1.429,1.604,1.826,1.8735,1.9385,2.0615,Q921I1,Q921I1,Tf,1,13,38,3,Q921I1,MOUSE,78890.5,52.6,135,135.2,544.25,51.74,NA,697,Serotransferrin,extracellular space|endosome|early endosome|late endosome|coated pit|basal plasma membrane|cell surface|membrane|cytoplasmic membrane-bounded vesicle|apical plasma membrane|vesicle coat|endocytic vesicle|vesicle|basal part of cell|perinuclear region of cytoplasm|recycling endosome|extracellular exosome|blood microparticle|dense body|,"iron ion transport|cellular iron ion homeostasis|actin filament organization|activation of JUN kinase activity|ferric iron transport|osteoclast differentiation|positive regulation of phosphorylation|positive regulation of bone resorption|positive regulation of transcription, DNA-templated|SMAD protein signal transduction|ERK1 and ERK2 cascade|positive regulation of cell motility|",protein binding|ferric iron binding|ferric iron transmembrane transporter activity|,3,13,2.20E+09,0.078,Q921I1,0.001233432,-0.2085,43.38917884,1.791666667,4.58E-05,9.585179602,-0.873,-0.951,-1.489,0.588,0.575,0.899,PC,9,TRUE,NA
0.1325,0.78,1.38,-0.166,0.509,1.141,-0.1465,0.5365,1.1975,P97501,P97501,Fmo3,1,212,35,34,P97501|J3QMN6|A0A0J9YUC0,MOUSE,61199.5,64.4,148,148.1,563.25,548.65,NA,534,Dimethylaniline monooxygenase [N-oxide-forming] 3,endoplasmic reticulum membrane|integral component of membrane|,drug metabolic process|oxidation-reduction process|,"N,N-dimethylaniline monooxygenase activity|trimethylamine monooxygenase activity|flavin adenine dinucleotide binding|NADP binding|",35,212,6.08E+11,0.644,P97501,0.418276422,-0.215333333,9.220101565,0.596666667,0.119671254,1.791627285,0.153,-0.437,-1.257,0.22,0.001,0.028,undefined,6,NA,TRUE
0.5385,0.476,-0.177,0.765,0.722,0.081,0.9975,1.0045,0.3045,Q3V117,Q3V117,Acly,1,97,39,39,Q3V117|Q91V92|Q3TS02,MOUSE,121705.9,41.7,194,194.1,505.33,505.33,NA,1101,ATP-citrate synthase,intracellular|nucleoplasm|cytoplasm|mitochondrion|plasma membrane|membrane|extracellular exosome|,acetyl-CoA biosynthetic process|citrate metabolic process|fatty acid biosynthetic process|lipid biosynthetic process|cellular carbohydrate metabolic process|,ATP citrate synthase activity|ATP binding|cofactor binding|,39,97,2.24E+10,0.417,Q3V117,0.291066316,-0.0675,12.54676761,0.502333333,0.055631816,2.327931957,-0.564,-0.526,0.134,-0.034,0.178,0.407,NC,5,NA,NA
0.1005,0.808,1.44,0.091,0.78,1.383,-0.3795,0.2965,0.9635,Q8VCH0,Q8VCH0,Acaa1b,1,99,26,10,Q8VCH0,MOUSE,44508.1,80.1,195,195.2,501.37,207.41,NA,424,"3-ketoacyl-CoA thiolase B, peroxisomal",mitochondrion|peroxisome|,fatty acid metabolic process|,acetyl-CoA C-acyltransferase activity|,10,99,1.99E+11,0.287,Q8VCH0,0.430942063,-0.182333333,8.89890973,0.606666667,0.1288573,1.739653308,0.182,-0.41,-1.229,0.265,0.273,-0.175,NC,5,NA,NA
1.3425,1.195,2.161,1.394,1.245,2.29,1.3045,1.1485,2.2635,Q8K169,Q8K169,Ugt2b5,1,157,29,6,Q8K169|P17717,MOUSE,61443.5,60.5,196,196.1,501.02,122.74,NA,530,UDP-glucuronosyltransferase,mitochondrial inner membrane|endoplasmic reticulum|intracellular membrane-bounded organelle|,flavonoid biosynthetic process|cellular response to hormone stimulus|flavonoid glucuronidation|,glucuronosyltransferase activity|,29,157,8.39E+11,0.605,Q8K169,0.025003286,-0.281666667,27.30572856,1.589333333,0.001859633,5.048454646,-0.765,-0.613,-1.851,0.457,0.55,0.532,undefined,9,TRUE,TRUE
1.4575,1.352,2.385,1.515,1.35,2.368,1.3285,1.2355,2.2675,Q8BWQ1,Q8BWQ1,Ugt2a3,1,101,26,23,Q8BWQ1|A0A0J9YU36|Q80X89|Q6PDD0|D3YUX6,MOUSE,61860,56.5,196,196.2,373.76,329.28,NA,534,UDP-glucuronosyltransferase 2A3,integral component of membrane|intracellular membrane-bounded organelle|,flavonoid biosynthetic process|cellular response to hormone stimulus|cellular glucuronidation|flavonoid glucuronidation|,glucuronosyltransferase activity|,23,101,1.94E+11,0.524,Q8BWQ1,0.023363073,-0.283333333,27.68312502,1.72,0.001704855,5.131370547,-0.832,-0.636,-1.962,0.591,0.671,0.468,undefined,9,TRUE,TRUE
0.9675,0.624,2.123,0.644,0.359,1.822,0.8515,0.5435,2.0015,Q8R084,Q8R084,Ugt2b1,1,143,25,22,Q8R084,MOUSE,60840.8,49.5,196,196.3,386.27,338.4,NA,529,UDP-glucuronosyltransferase,intracellular membrane-bounded organelle|,flavonoid biosynthetic process|response to lipopolysaccharide|cellular response to hormone stimulus|cellular glucuronidation|flavonoid glucuronidation|biphenyl catabolic process|cellular response to ethanol|cellular response to growth hormone stimulus|cellular response to glucocorticoid stimulus|cellular response to testosterone stimulus|,glucuronosyltransferase activity|,22,143,1.89E+11,0.449,Q8R084,0.232765432,-0.292333333,14.36959701,1.181333333,0.036562872,2.625587201,-0.486,-0.172,-1.991,0.381,0.155,0.359,undefined,8,TRUE,TRUE
1.0655,0.514,1.739,1.461,0.938,1.927,1.0135,0.5005,1.7855,Q3UEP4,Q3UEP4,Ugt2b36,1,49,22,15,Q3UEP4,MOUSE,61610.8,49.8,196,196.7,294.28,198.55,NA,530,UDP-glucuronosyltransferase,intracellular membrane-bounded organelle|extracellular exosome|,flavonoid biosynthetic process|aromatic compound catabolic process|cellular response to hormone stimulus|response to drug|flavonoid glucuronidation|,glucuronosyltransferase activity|,15,49,2.41E+10,0.383,Q3UEP4,0.091964402,-0.257833333,20.30688871,1.201666667,0.009317752,3.651993128,-0.758,-0.24,-1.578,0.225,0.595,0.209,undefined,9,TRUE,TRUE
0.7925,1.013,1.33,0.248,0.421,0.821,0.2735,0.5335,0.8675,B2RT14,B2RT14,Ugt1a5,1,15,18,6,B2RT14,MOUSE,60756.8,33.6,196,196.11,248.47,62.75,NA,529,UDP-glucuronosyltransferase,endoplasmic reticulum|endoplasmic reticulum membrane|intracellular membrane-bounded organelle|,flavonoid biosynthetic process|cellular response to hormone stimulus|cellular glucuronidation|flavonoid glucuronidation|xenobiotic glucuronidation|,glucuronosyltransferase activity|enzyme binding|protein homodimerization activity|protein heterodimerization activity|,6,15,3.68E+09,0.143,B2RT14,0.145050033,-0.040833333,17.57840697,0.689666667,0.017464627,3.166772797,-0.077,-0.285,-0.795,0.604,0.1,0.208,undefined,6,TRUE,TRUE
1.8275,1.832,2.103,2.122,1.97,2.26,1.8755,1.9115,2.2765,Q8QZR3,Q8QZR3,Ces2a,1,47,17,12,Q8QZR3|Q8QZR3-2,MOUSE,62395.6,43.1,223,223.2,249.87,196.72,NA,558,Pyrethroid hydrolase Ces2a,NA,NA,carboxylic ester hydrolase activity|,12,47,2.23E+10,0.374,Q8QZR3,0.000385808,-0.324333333,51.17094148,2.045333333,7.64E-06,12.80020873,-1.212,-1.139,-1.69,0.589,0.796,0.71,PC,9,TRUE,NA
0.0975,1.367,0.903,-0.087,1.247,0.764,-0.1785,1.2155,0.6645,Q91VI7,Q91VI7,Rnh1,1,89,27,27,A0A1B0GSG5|Q91VI7,MOUSE,51527.2,79.3,261,261.1,426.92,426.92,NA,456,Ribonuclease inhibitor,cytoplasm|angiogenin-PRI complex|extracellular exosome|,negative regulation of catalytic activity|regulation of angiogenesis|,ribonuclease inhibitor activity|,27,89,2.96E+10,0.793,Q91VI7,0.350456404,-0.219333333,10.99534572,0.605333333,0.079517996,2.077597828,0.156,-1.042,-0.68,0.205,0.045,0,undefined,6,NA,NA
0.4005,0.654,0.614,0.752,1.068,0.96,0.4995,0.8195,0.7675,O88844,O88844,Idh1,1,120,31,30,O88844,MOUSE,47073,70.7,263,263.1,425.07,411.64,NA,414,Isocitrate dehydrogenase [NADP] cytoplasmic,cytoplasm|mitochondrion|peroxisome|cytosol|extracellular exosome|,glyoxylate cycle|tricarboxylic acid cycle|isocitrate metabolic process|2-oxoglutarate metabolic process|glutathione metabolic process|response to oxidative stress|female gonad development|response to steroid hormone|regulation of phospholipid catabolic process|regulation of phospholipid biosynthetic process|,magnesium ion binding|isocitrate dehydrogenase (NADP+) activity|receptor binding|protein homodimerization activity|NADP binding|NAD binding|,31,120,5.02E+10,0.707,O88844,0.023252792,-0.034833333,27.72040956,0.703,0.001690282,5.139610175,-0.21,-0.454,-0.495,0.141,0.547,0.262,NC,6,NA,NA
-0.1015,-1.089,0.447,2.226,1.255,2.693,0.9225,-0.0935,1.3485,P25688,P25688,Uox,1,104,26,26,P25688|D3Z4U1,MOUSE,35266.7,69.9,332,332.1,366.38,366.38,NA,303,Uricase,mitochondrion|peroxisome|,purine nucleobase metabolic process|urate catabolic process|oxidation-reduction process|,urate oxidase activity|,26,104,4.96E+10,0.699,P25688,0.511980039,0.028333333,7.108273158,0.919333333,0.194613375,1.446362035,-0.54,0.453,-1.207,-0.541,1.673,0.332,NC,5,NA,NA
0.5105,0.186,0.622,1.168,0.875,1.326,0.8665,0.5575,1.0505,Q91ZJ5,Q91ZJ5,Ugp2,1,86,27,27,Q91ZJ5|Q91ZJ5-2,MOUSE,57149.4,59.4,339,339.1,359.7,359.7,NA,508,UTP--glucose-1-phosphate uridylyltransferase,nucleus|cytoplasm|extracellular exosome|,UDP-glucose metabolic process|glucose 1-phosphate metabolic process|,UTP:glucose-1-phosphate uridylyltransferase activity|glucose binding|pyrimidine ribonucleotide binding|identical protein binding|metal ion binding|,27,86,2.64E+10,0.594,Q91ZJ5,0.069485721,-0.0035,21.88014657,0.802333333,0.006486125,3.945013593,-0.423,-0.123,-0.668,0.065,0.705,0.423,undefined,7,NA,NA
-1.1255,0.677,1.491,-0.535,1.172,1.993,-1.7065,0.1005,1.0745,P52843,P52843,Sult2a1,1,129,23,11,P52843|V9GWV0,MOUSE,33326.8,61.4,346,346.1,356.37,166.55,NA,285,Bile salt sulfotransferase 1,cytoplasm|,steroid metabolic process|,sulfotransferase activity|bile-salt sulfotransferase activity|,23,129,1.49E+11,0.614,P52843,0.869941546,0.0355,1.617687411,0.278333333,0.689019097,0.418599803,1.348,-0.314,-1.345,0.126,0.727,-0.329,undefined,5,NA,NA
2.2495,2.223,2.148,2.103,2.18,2.111,2.4785,2.4475,2.4485,Q63880,Q63880,Ces3a,1,162,22,10,Q63880|Q63880-2,MOUSE,63715.9,46.2,349,349.1,354.29,189.74,NA,571,Carboxylesterase 3A,endoplasmic reticulum lumen|extracellular exosome|,metabolic process|,carboxylic ester hydrolase activity|,22,162,7.82E+11,0.462,Q63880,0.000114593,-0.282,60.59998875,2.24,8.71E-07,18.04072568,-1.472,-1.364,-1.37,0.697,0.728,1.089,PC,9,TRUE,NA
2.0915,1.988,2.376,1.824,1.668,2.274,2.2135,2.2455,2.6885,Q8VCU1,Q8VCU1,Ces3b,1,53,22,10,Q8VCU1|Q8VCU1-2,MOUSE,63751.2,53.5,349,349.2,350.41,185.86,NA,571,Carboxylesterase 3B,endoplasmic reticulum lumen|extracellular exosome|,metabolic process|,carboxylic ester hydrolase activity|,10,53,8.59E+10,0.373,Q8VCU1,0.001240397,-0.218833333,43.31150441,2.208333333,4.66E-05,9.557149135,-1.182,-1.056,-1.731,0.818,0.597,1.241,PC,9,TRUE,TRUE
0.5415,0.749,1.02,0.076,0.298,0.562,0.4505,0.6955,0.8805,Q9D2R0,Q9D2R0,Aacs,1,64,22,22,Q9D2R0,MOUSE,75712.4,35.7,445,445.1,296.39,296.39,NA,672,Acetoacetyl-CoA synthetase,cytosol|,liver development|fatty acid metabolic process|response to nutrient|response to purine-containing compound|positive regulation of insulin secretion|response to oleic acid|response to drug|response to starvation|response to ethanol|white fat cell differentiation|adipose tissue development|cellular response to glucose stimulus|cellular response to testosterone stimulus|cellular response to cholesterol|,ATP binding|acetoacetate-CoA ligase activity|butyrate-CoA ligase activity|,22,64,2.82E+10,0.357,Q9D2R0,0.134178597,-0.001333333,18.13472411,0.568,0.015364824,3.263579522,-0.042,-0.223,-0.591,0.405,0.037,0.406,undefined,5,NA,NA
1.0555,1.268,1.493,1.392,1.629,1.85,1.2175,1.4705,1.6915,G3UWS4,G3UWS4,Ppp2r1b,1,2,6,2,G3UWS4|H3BKU1|Q3TTF6|Q7TNP2|H3BLQ0|H3BLE7|H3BIV7,MOUSE,76804.9,10,494,494.2,67.73,15.61,NA,694,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform,membrane raft|extracellular exosome|,protein complex assembly|regulation of protein phosphatase type 2A activity|apoptotic process involved in morphogenesis|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand|,protein phosphatase type 2A regulator activity|,2,2,75200000,0.028,G3UWS4,0.007585153,-0.211833333,33.70821467,1.549666667,0.000425773,6.586982647,-0.633,-0.827,-1.5,0.355,0.744,0.59,undefined,9,NA,NA
0.4155,0.285,0.466,0.679,0.671,0.816,0.9265,0.8735,1.0495,P22599,P22599,Serpina1b,1,17,15,3,P22599,MOUSE,46145,31.9,515,515.2,201.14,48.13,NA,413,Alpha-1-antitrypsin 1-2,extracellular region|extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,in utero embryonic development|protein N-linked glycosylation|acute-phase response|negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|protein binding|identical protein binding|,3,17,6.93E+09,0.096,P22599,0.036506507,0.043666667,25.34600681,0.698,0.002920111,4.631571938,-0.285,-0.218,-0.413,0.085,0.47,0.623,PC,6,TRUE,NA
0.4195,0.223,-0.311,1.127,1.039,0.552,1.2975,1.1875,0.7255,P14824,P14824,Anxa6,1,47,21,21,P14824|F8WIT2,MOUSE,76340.4,34.1,532,532.1,261.55,261.55,NA,673,Annexin A6,mitochondrion|lysosomal membrane|cytosol|focal adhesion|membrane|late endosome membrane|melanosome|perinuclear region of cytoplasm|extracellular exosome|,calcium ion transport|regulation of muscle contraction|ion transmembrane transport|protein homooligomerization|mitochondrial calcium ion homeostasis|apoptotic signaling pathway|,calcium ion binding|GTP binding|calcium-dependent phospholipid binding|lipid binding|ligand-gated ion channel activity|cholesterol binding|protein homodimerization activity|calcium-dependent protein binding|,21,47,9.29E+09,0.341,P14824,0.265849697,0.116166667,13.37451597,0.680333333,0.045977823,2.462462549,-0.52,-0.301,0.149,-0.088,0.634,0.823,undefined,5,NA,NA
1.7875,1.926,1.839,2.153,2.198,2.247,1.8905,1.9595,1.8655,Q03311,Q03311,Bche,1,46,15,15,Q03311,MOUSE,68974.5,33.6,610,610.1,231.33,231.33,NA,603,Cholinesterase,nuclear envelope lumen|endoplasmic reticulum|endoplasmic reticulum lumen|membrane|blood microparticle|,learning|negative regulation of cell proliferation|neuroblast differentiation|choline metabolic process|response to drug|response to alkaloid|negative regulation of synaptic transmission|response to glucocorticoid|response to folic acid|,acetylcholinesterase activity|cholinesterase activity|choline binding|identical protein binding|,15,46,1.08E+10,0.336,Q03311,0.000269332,-0.311833333,53.43376309,1.956333333,4.54E-06,13.90670033,-1.187,-1.216,-1.467,0.482,0.911,0.606,PC,9,TRUE,TRUE
1.1865,0.962,0.987,0.779,0.811,0.601,0.9635,0.8395,0.6735,Q8R4U0,Q8R4U0,Stab2,1,33,19,19,Q8R4U0,MOUSE,289109.6,11.6,628,628.1,223.78,223.78,NA,2559,Stabilin-2,cytoplasm|integral component of plasma membrane|external side of plasma membrane|,endocytosis|receptor-mediated endocytosis|cell adhesion|regulation of gene expression|regulation of blood coagulation|defense response to bacterium|,low-density lipoprotein receptor activity|scavenger receptor activity|hyaluronic acid binding|low-density lipoprotein particle binding|,19,33,1.15E+09,0.116,Q8R4U0,0.002128357,-0.053333333,40.0029848,0.887333333,9.99E-05,8.383605749,-0.578,-0.537,-0.376,0.55,0.3,0.321,undefined,8,TRUE,TRUE
3.2065,3.427,2.659,3.484,3.955,3.161,3.2265,3.3855,2.9105,Q8VC81,Q8VC81,Pla2g12b,1,35,11,11,Q8VC81|Q99P27,MOUSE,22577.4,71.7,819,819.1,176.24,176.24,NA,195,Group XIIB phospholipase A2-like protein,extracellular region|,lipid catabolic process|cholesterol homeostasis|triglyceride homeostasis|,phospholipase A2 activity|calcium ion binding|,11,35,1.48E+10,0.717,Q8VC81,8.04E-05,-0.604,64.70693215,3.246666667,3.38E-07,20.91880865,-2.28,-2.377,-2.025,0.824,1.295,0.939,PC,9,TRUE,NA
0.4725,0.382,-0.082,1.185,1.129,0.91,0.8565,0.7955,0.5285,H3BKH6,H3BKH6,Esd,1,28,11,11,H3BKH6|Q9R0P3|H3BJL6|H3BLJ9|H3BK43,MOUSE,33399.4,48.4,842,842.1,171.72,171.72,NA,295,S-formylglutathione hydrolase,nucleoplasm|cytoplasm|Golgi apparatus|plasma membrane|extracellular exosome|,formaldehyde catabolic process|,"hydrolase activity, acting on ester bonds|S-formylglutathione hydrolase activity|",11,28,2.07E+10,0.484,H3BKH6,0.195515658,0.128666667,15.49489737,0.660666667,0.028216963,2.812413882,-0.395,-0.253,0.043,-0.003,0.876,0.504,undefined,5,NA,NA
1.7675,1.816,1.712,2.221,2.251,2.147,1.5505,1.6635,1.5175,P34927,P34927,Asgr1,1,32,10,10,P34927|B1AR34,MOUSE,33161.5,31.6,960,960.1,148.87,148.87,NA,284,Asialoglycoprotein receptor 1,integral component of membrane|,receptor-mediated endocytosis|cellular response to extracellular stimulus|,asialoglycoprotein receptor activity|carbohydrate binding|protein homodimerization activity|metal ion binding|,10,32,2.17E+10,0.316,P34927,0.00095391,-0.136666667,44.89522843,1.856,3.24E-05,10.14329813,-1.007,-1.05,-1.137,0.606,1.214,0.554,undefined,9,NA,TRUE
0.9745,1.216,1.338,0.916,1.225,1.275,0.9765,1.2875,1.4395,P21614,P21614,Gc,1,17,12,12,P21614,MOUSE,55196.9,34,978,978.1,146.55,146.55,NA,476,Vitamin D-binding protein,extracellular space|cytosol|axon|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|,female pregnancy|lactation|response to nutrient levels|response to estradiol|vitamin D metabolic process|vitamin transport|,actin binding|vitamin transporter activity|calcidiol binding|,12,17,3.55E+09,0.34,P21614,0.001362723,-0.083833333,42.71280048,1.208333333,5.35E-05,9.343509637,-0.465,-0.75,-0.849,0.379,0.538,0.644,PC,9,TRUE,NA
0.6745,0.886,1.109,-0.039,0.03,0.285,0.4905,0.7195,0.9735,P53798,P53798,Fdft1,1,24,10,10,P53798|A0A286YD20,MOUSE,48838.1,33.8,1030,1030.1,138.27,138.27,NA,416,Squalene synthase,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,cholesterol biosynthetic process|isoprenoid biosynthetic process|farnesyl diphosphate metabolic process|oxidation-reduction process|,farnesyl-diphosphate farnesyltransferase activity|oxidoreductase activity|squalene synthase activity|,10,24,2.43E+09,0.338,P53798,0.232765432,0.061,14.37664734,0.559333333,0.036503564,2.626749388,-0.033,-0.19,-0.433,0.601,-0.114,0.535,undefined,5,NA,NA
1.7815,1.637,2.048,2.097,2.185,2.409,1.2065,1.1365,1.4985,E9Q8B5,E9Q8B5,Gm4788,1,24,12,12,E9Q8B5|E9PUM5|E9Q8B6,MOUSE,102688.5,18.8,1043,1043.1,136.96,136.96,NA,879,Predicted gene 4788,NA,NA,NA,12,24,2.44E+09,0.188,E9Q8B5,0.004356249,-0.027833333,36.40861471,1.435,0.000228633,7.331621661,-0.697,-0.482,-1.057,0.582,1.007,0.48,PC,9,TRUE,NA
0.5435,0.485,0.918,0.493,0.459,0.887,0.6225,0.6035,1.0325,P42230,P42230,Stat5a,1,3,12,3,P42230|B2C3G8,MOUSE,91400.2,17.5,1046,1046.2,116.19,15.67,NA,793,Signal transducer and activator of transcription 5A,nucleus|nucleoplasm|cytoplasm|cytosol|,"allantoin metabolic process|luteinization|natural killer cell differentiation|citrate metabolic process|2-oxoglutarate metabolic process|succinate metabolic process|oxaloacetate metabolic process|transcription, DNA-templated|regulation of transcription from RNA polymerase II promoter|isoleucine metabolic process|valine metabolic process|creatine metabolic process|fatty acid metabolic process|JAK-STAT cascade|female pregnancy|lactation|positive regulation of cell proliferation|peptidyl-tyrosine phosphorylation|regulation of steroid metabolic process|cytokine-mediated signaling pathway|taurine metabolic process|lipid storage|regulation of cell adhesion|regulation of epithelial cell differentiation|mammary gland development|positive regulation of natural killer cell differentiation|negative regulation of mast cell apoptotic process|T cell differentiation in thymus|prolactin signaling pathway|regulation of multicellular organism growth|positive regulation of multicellular organism growth|positive regulation of activated T cell proliferation|T cell homeostasis|negative regulation of apoptotic process|response to peptide hormone|positive regulation of interleukin-2 biosynthetic process|positive regulation of B cell differentiation|positive regulation of gamma-delta T cell differentiation|positive regulation of lymphocyte differentiation|negative regulation of erythrocyte differentiation|positive regulation of mitotic cell cycle|positive regulation of transcription from RNA polymerase II promoter|positive regulation of natural killer cell mediated cytotoxicity|creatinine metabolic process|development of secondary female sexual characteristics|development of secondary male sexual characteristics|Peyer's patch development|positive regulation of inflammatory response|positive regulation of mast cell differentiation|JAK-STAT cascade involved in growth hormone signaling pathway|prostate gland epithelium morphogenesis|epithelial cell differentiation involved in prostate gland development|mammary gland epithelium development|positive regulation of mast cell proliferation|cellular response to granulocyte macrophage colony-stimulating factor stimulus|",RNA polymerase II core promoter sequence-specific DNA binding|DNA binding|sequence-specific DNA binding transcription factor activity|signal transducer activity|protein binding|protein phosphatase binding|,3,3,62700000,0.041,P42230,0.053391517,-0.102666667,23.28962856,0.696,0.004688535,4.216979776,-0.294,-0.24,-0.818,0.212,0.185,0.339,undefined,6,NA,NA
-0.3375,1.062,0.825,-0.38,1.053,0.889,-0.1125,1.3045,1.1855,P02088,P02088,Hbb-b1,1,21,8,3,P02088,MOUSE,15954,68.7,1056,1056.2,117.19,50.5,NA,147,Hemoglobin subunit beta-1,hemoglobin complex|myelin sheath|,oxygen transport|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,3,21,3.74E+10,0.278,P02088,0.519555499,-0.124166667,6.954814132,0.520333333,0.201613025,1.420820851,0.496,-0.802,-0.847,-0.039,0.069,0.378,undefined,6,NA,NA
0.5875,0.598,0.759,0.857,0.884,0.996,0.5855,0.4585,0.6295,P35951,P35951,Ldlr,1,21,12,12,P35951|A0A1L1SRE8,MOUSE,98425.9,22.2,1160,1160.1,120.35,120.35,NA,862,Low-density lipoprotein receptor,lysosome|endosome|early endosome|late endosome|Golgi apparatus|plasma membrane|coated pit|external side of plasma membrane|cell surface|membrane|integral component of membrane|basolateral plasma membrane|low-density lipoprotein particle|receptor complex|apical part of cell|,lipid metabolic process|receptor-mediated endocytosis|cholesterol metabolic process|positive regulation of triglyceride biosynthetic process|regulation of phosphatidylcholine catabolic process|phospholipid transport|intestinal cholesterol absorption|cholesterol transport|low-density lipoprotein particle clearance|lipoprotein metabolic process|lipoprotein catabolic process|cholesterol homeostasis|cholesterol import|regulation of cholesterol homeostasis|,glycoprotein binding|low-density lipoprotein receptor activity|calcium ion binding|protein binding|low-density lipoprotein particle binding|very-low-density lipoprotein particle receptor activity|,12,21,8.22E+08,0.222,P35951,0.034425498,0.012833333,25.66229269,0.687666667,0.002715006,4.697354379,-0.248,-0.263,-0.482,0.219,0.647,0.204,undefined,8,TRUE,TRUE
0.4315,0.644,0.354,0.471,0.531,0.387,0.7355,0.8995,0.6235,P19221,P19221,F2,1,21,12,12,P19221|H7BX99,MOUSE,71693.8,18.7,1230,1230.1,110.97,110.97,NA,618,Prothrombin,extracellular space|cytosol|extracellular matrix|extracellular exosome|blood microparticle|,positive regulation of protein phosphorylation|proteolysis|acute-phase response|cell surface receptor signaling pathway|positive regulation of cell proliferation|regulation of cell shape|response to wounding|regulation of gene expression|positive regulation of phosphatidylinositol 3-kinase signaling|response to inactivity|platelet activation|positive regulation of blood coagulation|positive regulation of cell growth|positive regulation of collagen biosynthetic process|fibrinolysis|negative regulation of proteolysis|negative regulation of astrocyte differentiation|positive regulation of release of sequestered calcium ion into cytosol|cytosolic calcium ion homeostasis|thrombin receptor signaling pathway|cellular response to mechanical stimulus|positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway|positive regulation of reactive oxygen species metabolic process|,serine-type endopeptidase activity|receptor binding|calcium ion binding|protein binding|peptidase activity|thrombospondin receptor activity|,12,21,6.37E+09,0.187,P19221,0.034366646,0.008166667,25.69779754,0.479666667,0.0026929,4.689154741,-0.181,-0.293,-0.221,0.164,0.154,0.426,undefined,5,TRUE,NA
1.7275,1.672,2.056,1.56,1.458,1.841,1.4805,1.5075,1.8275,P41317,P41317,Mbl2,1,19,9,8,P41317,MOUSE,26356,50,1235,1235.2,110.76,105.75,NA,244,Mannose-binding protein C,collagen trimer|extracellular space|,"complement activation, lectin pathway|complement activation, classical pathway|negative regulation of growth of symbiont in host|innate immune response|negative regulation of viral process|positive regulation of phagocytosis|defense response to Gram-positive bacterium|killing by host of symbiont cells|",receptor binding|calcium ion binding|mannose binding|calcium-dependent protein binding|,8,19,6.29E+09,0.454,P41317,0.001446578,-0.272166667,42.36138067,1.686333333,5.81E-05,9.220075939,-0.937,-0.867,-1.542,0.61,0.549,0.554,PC,9,TRUE,NA
0.5185,0.459,0.533,0.66,0.755,0.653,0.6735,0.8225,0.7005,O70570,O70570,Pigr,1,17,9,9,O70570,MOUSE,86309.5,15.5,1251,1251.1,108.93,108.93,NA,771,Polymeric immunoglobulin receptor,extracellular space|plasma membrane|integral component of membrane|receptor complex|extracellular exosome|,detection of chemical stimulus involved in sensory perception of bitter taste|retina homeostasis|immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor|epidermal growth factor receptor signaling pathway|Fc receptor signaling pathway|receptor clustering|,polymeric immunoglobulin receptor activity|,9,17,9.67E+08,0.155,O70570,0.005827867,-0.0055,35.03004981,0.623,0.000314047,6.879072627,-0.305,-0.306,-0.34,0.169,0.338,0.411,PC,6,TRUE,TRUE
0.5165,0.362,0.574,1.332,1.236,1.383,0.4245,0.4615,0.6185,P12710,P12710,Fabp1,1,25,8,8,P12710,MOUSE,14302.4,63.7,1279,1279.1,104.79,104.79,NA,127,"Fatty acid-binding protein, liver",nucleus|cytoplasm|peroxisomal matrix|cytosol|apical cortex|extracellular exosome|,positive regulation of defense response to virus by host|positive regulation of cell proliferation|long-chain fatty acid transport|positive regulation of fatty acid beta-oxidation|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|intestinal absorption|positive regulation of hydrolase activity|cellular response to hydrogen peroxide|cellular response to hypoxia|activation of mitophagy in response to mitochondrial depolarization|,chromatin binding|long-chain fatty acid transporter activity|fatty acid binding|phospholipid binding|drug binding|antioxidant activity|bile acid binding|,8,25,3.89E+09,0.637,P12710,0.12890883,0.0685,18.3515179,0.729666667,0.014616662,3.301581754,-0.256,-0.202,-0.431,0.172,0.949,0.179,undefined,5,NA,NA
0.8005,0.804,0.843,0.82,0.856,0.917,0.8215,0.7895,0.8685,O88783,O88783,F5,1,12,9,9,O88783,MOUSE,248366.9,5.4,1284,1284.1,104.33,104.33,NA,2183,Coagulation factor V,extracellular space|membrane|platelet alpha granule|extracellular vesicle|,blood coagulation|blood circulation|platelet activation|,copper ion binding|,9,12,6.51E+08,0.054,O88783,0.000697718,-0.0915,46.95489976,0.842333333,2.02E-05,10.80454565,-0.492,-0.46,-0.586,0.301,0.323,0.365,PC,9,TRUE,NA
0.4575,0.475,0.398,0.858,0.787,0.649,0.7175,0.6515,0.6195,Q8VCN5,Q8VCN5,Cth,1,21,9,9,Q8VCN5,MOUSE,44194,31.6,1296,1296.1,102.79,102.79,NA,398,Cystathionine gamma-lyase,nucleus|nucleoplasm|cytoplasm|extracellular exosome|,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine|cysteine biosynthetic process|negative regulation of apoptotic process|positive regulation of I-kappaB kinase/NF-kappaB signaling|protein sulfhydration|positive regulation of NF-kappaB transcription factor activity|protein homotetramerization|hydrogen sulfide biosynthetic process|negative regulation of apoptotic signaling pathway|,cystathionine gamma-lyase activity|protein binding|calmodulin binding|pyridoxal phosphate binding|L-cystine L-cysteine-lyase (deaminating)|L-cysteine desulfhydrase activity|,9,21,2.06E+09,0.316,Q8VCN5,0.018143647,-0.0195,28.96891897,0.577,0.001267967,5.402449822,-0.388,-0.22,-0.316,0.094,0.396,0.317,NC,5,NA,NA
0.6155,0.431,0.481,0.56,0.585,0.412,1.0815,1.0895,0.8485,B8JJM5,B8JJM5,Cfb,1,22,11,11,B8JJN0|B8JJM5|P04186|B8JJM6|F6XQ00,MOUSE,86604.6,14.1,1322,1322.1,99.12,99.12,NA,763,Complement factor B,extracellular space|extracellular exosome|blood microparticle|,"proteolysis|complement activation, alternative pathway|cell proliferation|",serine-type endopeptidase activity|,11,22,3.84E+09,0.141,B8JJM5,0.032056142,-0.053,26.06571873,0.650666667,0.002474162,4.782080267,-0.459,-0.352,-0.324,0.159,0.102,0.556,PC,6,TRUE,NA
0.6775,0.797,0.674,0.559,0.784,0.464,0.3935,0.6495,0.4615,Q61508,Q61508,Ecm1,1,12,8,8,Q61508|F8WI14|Q61508-2,MOUSE,64485.6,18.9,1371,1371.1,92.2,92.2,NA,559,Extracellular matrix protein 1,proteinaceous extracellular matrix|extracellular space|extracellular matrix|extracellular exosome|,ossification|angiogenesis|positive regulation of endothelial cell proliferation|negative regulation of cytokine-mediated signaling pathway|regulation of type 2 immune response|regulation of transcription from RNA polymerase II promoter|inflammatory response|signal transduction|negative regulation of peptidase activity|negative regulation of bone mineralization|biomineral tissue development|positive regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of angiogenesis|regulation of T cell migration|,protease binding|signal transducer activity|interleukin-2 receptor binding|protein C-terminus binding|enzyme binding|laminin binding|,8,12,1.46E+09,0.189,Q61508,0.009180255,-0.0355,32.70897745,0.594333333,0.000535923,6.284820898,-0.218,-0.457,-0.323,0.34,0.246,0.199,PC,5,TRUE,NA
1.0545,0.95,0.228,1.1,1.194,0.444,1.5215,1.5585,0.7265,A6X935,A6X935,Itih4,1,12,8,8,A6X935|E9PVD2|E9Q5L2|A6X935-2|A0A0R4J1N1,MOUSE,104828.7,8.5,1375,1375.1,91.98,91.98,NA,942,"Inter alpha-trypsin inhibitor, heavy chain 4",cytoplasm|plasma membrane|extracellular exosome|blood microparticle|,acute-phase response|negative regulation of endopeptidase activity|hyaluronan metabolic process|response to cytokine|,serine-type endopeptidase inhibitor activity|protein binding|calcium ion binding|hyaluronic acid binding|,8,12,1.50E+09,0.085,A6X935,0.066117929,-0.106166667,22.150741,0.965,0.006094329,3.996504997,-0.844,-0.828,-0.094,0.127,0.329,0.673,PC,7,TRUE,NA
0.5015,0.322,-0.233,0.627,0.527,0.03,0.8165,0.7215,0.0945,P40124,P40124,Cap1,1,10,7,7,P40124,MOUSE,51906.2,22.1,1408,1408.1,88.52,88.52,NA,474,Adenylyl cyclase-associated protein 1,extracellular region|cytoplasm|cytosol|plasma membrane|focal adhesion|cortical actin cytoskeleton|extracellular exosome|,cell morphogenesis|ameboidal-type cell migration|receptor-mediated endocytosis|actin cytoskeleton organization|,actin binding|protein binding|,7,10,6.91E+08,0.221,P40124,0.399781712,-0.056166667,9.695350063,0.327666667,0.107266718,1.868333589,-0.505,-0.296,0.141,-0.037,0.142,0.218,PC,5,NA,NA
1.3045,0.91,1.167,0.801,0.479,0.49,1.4425,1.0965,1.1115,Q8BH35,Q8BH35,C8b,1,18,8,8,Q8BH35|Q8BH35-2,MOUSE,68053.9,20.3,1488,1488.1,82.11,82.11,NA,589,Complement component C8 beta chain,membrane attack complex|extracellular space|extracellular exosome|extracellular vesicle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",protein complex binding|,8,18,8.43E+08,0.203,Q8BH35,0.020608712,0.0445,28.36364434,0.957,0.001457591,5.28314393,-0.678,-0.253,-0.371,0.576,0.204,0.789,PC,7,TRUE,NA
1.0005,0.901,0.311,1.338,1.095,0.82,1.5175,1.4565,0.9025,Q8BXA1,Q8BXA1,Golim4,1,7,6,6,D3YVW2|Q8BXA1,MOUSE,76840.5,12.6,1489,1489.1,82.01,82.01,NA,655,Golgi integral membrane protein 4,nucleoplasm|Golgi apparatus|endosome membrane|membrane|integral component of membrane|Golgi cisterna membrane|,transport|,NA,6,7,1.79E+08,0.126,Q8BXA1,0.021640426,-0.0475,28.08310051,0.935666667,0.001554855,5.220218733,-0.726,-0.668,-0.152,0.219,0.474,0.568,undefined,8,NA,TRUE
0.5805,0.556,0.753,0.58,0.575,0.878,0.6025,0.6365,0.9015,P16301,P16301,Lcat,1,17,6,6,P16301,MOUSE,50088.2,16.2,1491,1491.1,81.9,81.9,NA,438,Phosphatidylcholine-sterol acyltransferase,extracellular space|high-density lipoprotein particle|extracellular exosome|,phospholipid metabolic process|phosphatidylcholine biosynthetic process|cholesterol metabolic process|cholesterol transport|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|cholesterol esterification|lipoprotein biosynthetic process|cholesterol homeostasis|reverse cholesterol transport|response to copper ion|response to glucocorticoid|regulation of high-density lipoprotein particle assembly|,phosphatidylcholine-sterol O-acyltransferase activity|phospholipase A2 activity|apolipoprotein A-I binding|,6,17,2.14E+09,0.162,P16301,0.011168288,-0.081333333,31.6140654,0.628666667,0.000689594,6.027719972,-0.33,-0.301,-0.556,0.165,0.189,0.345,PC,9,TRUE,NA
0.4205,0.522,0.333,0.645,0.721,0.607,0.5985,0.5625,0.3415,P55292,P55292,Dsc2,1,9,7,7,P55292|P55292-2,MOUSE,101100.7,9.9,1542,1542.1,78.59,78.59,NA,902,Desmocollin-2,plasma membrane|cell-cell adherens junction|intercalated disc|integral component of membrane|desmosome|cytoplasmic vesicle|extracellular exosome|,homophilic cell adhesion via plasma membrane adhesion molecules|cellular response to starvation|cardiac muscle cell-cardiac muscle cell adhesion|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|regulation of ventricular cardiac muscle cell action potential|,calcium ion binding|,7,9,2.73E+08,0.099,P55292,0.017764897,0.002666667,29.09556185,0.508666667,0.001231527,5.415286756,-0.24,-0.279,-0.236,0.128,0.398,0.245,undefined,5,TRUE,TRUE
0.3025,0.36,0.727,0.489,0.454,0.76,0.6505,0.7295,1.0685,Q80X50-5,Q80X50,Ubap2l,1,12,6,6,Q80X50-5|Q80X50|Q80X50-4|Q80X50-3|A0A0G2JDV6|Q80X50-2|A0A0H2UH17,MOUSE,117446.7,8.9,1610,1610.1,73.06,73.06,NA,1107,Isoform 5 of Ubiquitin-associated protein 2-like,Ada2/Gcn5/Ada3 transcription activator complex|PcG protein complex|,binding of sperm to zona pellucida|hematopoietic stem cell homeostasis|,poly(A) RNA binding|,6,12,1.27E+09,0.089,Q80X50-5,0.078229733,-0.0615,21.20624879,0.589666667,0.007574869,3.818200727,-0.203,-0.224,-0.642,0.076,0.201,0.423,undefined,5,NA,NA
1.2965,1.184,1.224,1.228,1.154,1.178,1.3415,1.5335,1.6965,Q01339,Q01339,Apoh,1,12,7,7,Q01339,MOUSE,39930.4,25.7,1709,1709.1,65.54,65.54,NA,345,Beta-2-glycoprotein 1,extracellular space|cell surface|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|extracellular matrix|,"negative regulation of endothelial cell proliferation|triglyceride metabolic process|blood coagulation, intrinsic pathway|negative regulation of endothelial cell migration|negative regulation of angiogenesis|regulation of blood coagulation|negative regulation of blood coagulation|organ regeneration|plasminogen activation|negative regulation of myeloid cell apoptotic process|negative regulation of smooth muscle cell apoptotic process|positive regulation of lipoprotein lipase activity|regulation of fibrinolysis|negative regulation of fibrinolysis|",glycoprotein binding|phospholipid binding|heparin binding|lipid binding|identical protein binding|lipoprotein lipase activator activity|,7,12,7.15E+08,0.257,Q01339,0.000355429,-0.0855,51.81518669,1.272333333,6.58E-06,12.96433194,-0.707,-0.665,-0.793,0.463,0.481,0.708,PC,9,TRUE,NA
1.0195,1.11,1.317,1.02,1.199,1.399,1.0475,1.1735,1.4845,P26262,P26262,Klkb1,1,6,4,4,P26262,MOUSE,73492.3,8.7,1898,1898.1,52.89,52.89,NA,638,Plasma kallikrein,extracellular space|extracellular exosome|,inflammatory response|blood coagulation|plasminogen activation|fibrinolysis|positive regulation of fibrinolysis|liver regeneration|,serine-type endopeptidase activity|,4,6,1.99E+08,0.087,P26262,0.003394463,-0.15,37.60973319,1.221333333,0.000173391,7.683874222,-0.544,-0.635,-1.103,0.374,0.445,0.563,PC,9,TRUE,NA
0.6625,0.645,0.787,0.56,0.423,0.693,0.7625,0.6755,0.6215,Q91WP0,Q91WP0,Masp2,1,7,6,6,Q91WP0,MOUSE,76998.6,10.5,1952,1952.1,50.02,50.02,NA,685,Mannan-binding lectin serine protease 2,extracellular exosome|,"complement activation, lectin pathway|proteolysis|complement activation, classical pathway|",complement component C4b binding|serine-type endopeptidase activity|calcium ion binding|protein binding|peptidase activity|calcium-dependent protein binding|,6,7,1.68E+09,0.105,Q91WP0,0.009126894,-0.058166667,32.79738955,0.579,0.000525123,6.295504679,-0.389,-0.213,-0.441,0.245,0.173,0.276,PC,7,TRUE,NA
1.2055,0.862,1.039,1.322,1.003,1.175,1.1255,0.8215,0.9945,Q8R093,Q8R093,Upp2,1,8,5,5,Q8R093|A2APN2|Q8CGR7,MOUSE,38544.7,23.6,1960,1960.1,49.63,49.63,NA,338,Uridine phosphorylase,cytoplasm|type III intermediate filament|,nucleotide catabolic process|UMP salvage|,uridine phosphorylase activity|,5,8,1.03E+09,0.236,Q8R093,0.001458916,-0.1355,42.17626132,1.069,6.06E-05,9.15563042,-0.794,-0.462,-0.754,0.351,0.512,0.334,undefined,9,NA,NA
1.1825,0.672,0.768,1.475,0.952,1.189,1.6295,1.1205,1.3185,Q3TAS6,Q3TAS6,Emc10,1,5,3,3,A0A0KG67|A0A0KG66|Q3TAS6|Q3TAS6-2,MOUSE,27280.3,20.9,2036,2036.1,46.45,46.45,NA,258,ER membrane protein complex subunit 10,extracellular region|integral component of membrane|ER membrane protein complex|,NA,NA,3,5,3.08E+08,0.209,Q3TAS6,0.006583738,-0.038666667,34.41087215,1.116666667,0.00036217,6.774709744,-0.854,-0.388,-0.549,0.272,0.564,0.723,PC,9,TRUE,TRUE
0.9975,0.939,0.561,0.488,0.532,0.192,1.2065,1.2645,0.9295,E9Q6C2,E9Q6C2,C1s1,1,4,4,4,E9Q6C2|Q8CG14|A0A1W2P7F1|Q8CFG8,MOUSE,79039.3,10.3,2133,2133.1,42.03,42.03,NA,694,"Complement component 1, s subcomponent 1",extracellular exosome|blood microparticle|,proteolysis|complement activation|,serine-type endopeptidase activity|calcium ion binding|identical protein binding|,4,4,2.75E+08,0.103,E9Q6C2,0.06243009,0.077833333,22.49637909,0.802333333,0.005628104,4.062766417,-0.469,-0.42,-0.081,0.465,0.138,0.834,undefined,6,TRUE,NA
0.7205,0.807,0.576,0.777,0.884,0.867,0.6705,0.9085,0.7675,Q8C7G5,Q8C7G5,Apoa5,1,7,3,3,Q8C7G5|A0A1L1SQP3,MOUSE,41318.5,9.5,2151,2151.1,41.47,41.47,NA,368,Apolipoprotein A-V,extracellular region|extracellular space|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|blood microparticle|,triglyceride metabolic process|cholesterol biosynthetic process|lipid transport|response to hormone|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|positive regulation of very-low-density lipoprotein particle remodeling|triglyceride catabolic process|regulation of intestinal cholesterol absorption|organ regeneration|neuron projection regeneration|cholesterol efflux|phospholipid efflux|triglyceride-rich lipoprotein particle remodeling|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|lipoprotein metabolic process|tissue regeneration|cholesterol homeostasis|reverse cholesterol transport|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|positive regulation of lipid catabolic process|positive regulation of lipoprotein lipase activity|acylglycerol homeostasis|triglyceride homeostasis|,phospholipid binding|enzyme activator activity|heparin binding|lipid binding|cholesterol binding|cholesterol transporter activity|enzyme binding|phosphatidylcholine binding|lipase binding|low-density lipoprotein particle receptor binding|phosphatidylcholine-sterol O-acyltransferase activator activity|lipase activator activity|lipoprotein lipase activator activity|lipoprotein particle receptor binding|,3,7,1.83E+08,0.095,Q8C7G5,0.002128357,-0.0395,39.98462011,0.687666667,0.000100355,8.328836994,-0.375,-0.479,-0.296,0.277,0.319,0.317,PC,8,TRUE,NA
0.2305,-0.018,-0.004,1.301,0.947,1.065,0.8425,0.6565,0.8965,P40936,P40936,Inmt,1,12,4,4,P40936,MOUSE,30086.8,16.2,2192,2192.1,39.7,39.7,NA,264,Indolethylamine N-methyltransferase,cytosol|,amine metabolic process|response to toxic substance|methylation|,thioether S-methyltransferase activity|amine N-methyltransferase activity|,4,12,1.83E+09,0.162,P40936,0.243045155,0.178,14.00036803,0.611333333,0.039807344,2.56485546,-0.275,-0.037,-0.071,-0.038,0.923,0.566,undefined,6,NA,NA
0.5585,0.742,0.789,0.44,0.488,0.476,0.6925,0.9155,0.9575,P70375,P70375,F7,1,6,3,3,P70375,MOUSE,51701.8,10,2288,2288.1,36.12,36.12,NA,446,Coagulation factor VII,extracellular region|extracellular space|vesicle|,positive regulation of leukocyte chemotaxis|proteolysis|blood coagulation|circadian rhythm|positive regulation of platelet-derived growth factor receptor signaling pathway|positive regulation of blood coagulation|organ regeneration|response to vitamin K|response to estrogen|positive regulation of positive chemotaxis|positive regulation of protein kinase B signaling|response to growth hormone|,glycoprotein binding|serine-type endopeptidase activity|receptor binding|calcium ion binding|,3,6,40100000,0.1,P70375,0.014006457,-0.000666667,30.34419673,0.554,0.000923805,5.711251166,-0.272,-0.263,-0.298,0.248,0.146,0.435,PC,6,TRUE,NA
0.5225,0.58,0.814,0.744,0.755,1.091,0.5115,0.5045,0.9975,Q9D8N2,Q9D8N2,Fam45a,1,4,4,4,Q9D8N2|Q3TH34,MOUSE,40762.5,17.9,2295,2295.1,35.87,35.87,NA,357,Protein FAM45A,NA,NA,NA,4,4,86800000,0.179,Q9D8N2,0.043350152,-0.051333333,24.39154007,0.726666667,0.00363786,4.436381183,-0.206,-0.274,-0.764,0.263,0.447,0.226,undefined,8,NA,NA
0.5805,0.684,0.491,0.653,0.6,0.239,0.7975,0.6785,0.3195,P46938,P46938,Yap1,1,4,3,3,P46938|P46938-2|G3UYV4|G3UY62|G3UYA6,MOUSE,52439.5,7.5,2323,2323.1,34.76,34.76,NA,488,Transcriptional coactivator YAP1,nucleus|nucleoplasm|transcription factor complex|cytoplasm|cytosol|membrane|cell junction|,"cell morphogenesis|vasculogenesis|embryonic heart tube morphogenesis|transcription, DNA-templated|cellular response to DNA damage stimulus|DNA damage induced protein phosphorylation|cell proliferation|positive regulation of cell proliferation|regulation of keratinocyte proliferation|keratinocyte differentiation|negative regulation of epithelial cell differentiation|notochord development|somatic stem cell maintenance|hippo signaling|regulation of cell proliferation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of organ growth|paraxial mesoderm development|lateral mesoderm development|regulation of neurogenesis|contact inhibition|bud elongation involved in lung branching|lung epithelial cell differentiation|regulation of canonical Wnt signaling pathway|cellular response to retinoic acid|cellular response to gamma radiation|regulation of stem cell proliferation|regulation of metanephric nephron tubule epithelial cell differentiation|positive regulation of canonical Wnt signaling pathway|positive regulation of stem cell maintenance|negative regulation of nucleic acid-templated transcription|negative regulation of stem cell differentiation|negative regulation of extrinsic apoptotic signaling pathway|",RNA polymerase II core promoter sequence-specific DNA binding|RNA polymerase II transcription factor binding transcription factor activity|chromatin binding|transcription coactivator activity|transcription corepressor activity|protein binding|protein C-terminus binding|transcription regulatory region DNA binding|proline-rich region binding|,3,4,46100000,0.075,P46938,0.02360757,-0.030666667,27.60463246,0.478,0.001735948,5.08455457,-0.303,-0.351,-0.155,0.283,0.105,0.237,undefined,6,NA,NA
1.1325,1.24,1.339,0.609,0.776,0.869,0.1995,0.2895,0.2705,P19783,P19783,Cox4i1,1,6,3,3,P19783,MOUSE,19587.2,16.5,2376,2376.1,32.67,32.67,NA,169,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial",nucleus|mitochondrion|mitochondrial inner membrane|membrane|mitochondrial membrane|extracellular exosome|,response to nutrient|hydrogen ion transmembrane transport|,cytochrome-c oxidase activity|,3,6,7.23E+08,0.165,P19783,0.158446457,0.17,17.0455032,0.702,0.019744661,3.074957871,-0.133,-0.159,-0.251,1.023,0.462,0.078,NC,6,NA,TRUE
0.6265,0.392,1.063,0.895,0.686,1.351,1.0785,0.8835,1.5505,G3X9H7,G3X9H7,Mtss1,1,3,3,3,G3X9H7|Q8R1S4|Q8R1S4-2,MOUSE,83048.4,9.2,2446,2446.1,30.38,30.38,NA,759,"Metastasis suppressor 1, isoform CRA_e",cytoplasm|adherens junction|actin cytoskeleton|,in utero embryonic development|positive regulation of defense response to virus by host|plasma membrane organization|actin filament organization|magnesium ion homeostasis|actin filament polymerization|bone mineralization|positive regulation of actin filament bundle assembly|adherens junction maintenance|renal system development|,actin binding|actin monomer binding|receptor binding|identical protein binding|actin filament binding|,3,3,83900000,0.092,G3X9H7,0.038251392,-0.0435,25.03785726,1.052333333,0.003134832,4.568015099,-0.442,-0.222,-1.045,0.224,0.561,0.663,undefined,8,NA,NA
0.8515,0.641,-0.32,0.735,0.557,-0.222,1.3985,1.2355,0.2575,Q8BT60,Q8BT60,Cpne3,1,4,3,2,Q8BT60,MOUSE,60325.6,5.2,2454,2454.2,23.62,17.43,NA,533,Copine-3,nucleus|cytoplasm|cytosol|plasma membrane|extracellular exosome|,protein phosphorylation|cellular response to calcium ion|,protein serine/threonine kinase activity|poly(A) RNA binding|,2,4,4.10E+08,0.035,Q8BT60,0.432325921,-0.061666667,8.825847872,0.567333333,0.131043418,1.727812109,-0.796,-0.604,0.364,0.062,-0.006,0.61,undefined,6,NA,NA
2.6415,2.582,2.865,2.787,2.752,3.109,2.4885,2.4685,2.7695,D3Z4E2,D3Z4E2,Nrn1,1,6,2,2,D3Z4E2|A0A286YD56|Q8CFV4,MOUSE,17406.3,17,2530,2530.1,27.94,27.94,NA,158,Neuritin,alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex|,axonogenesis|,NA,2,6,1.26E+09,0.17,D3Z4E2,0.000244416,-0.500166667,55.30218321,2.740333333,2.95E-06,14.88763945,-1.734,-1.616,-2.261,0.808,1.043,0.759,PC,9,NA,TRUE
0.7815,0.714,0.452,0.692,0.649,0.383,0.7565,0.7285,0.4625,P25446,P25446,Fas,1,3,2,2,P25446,MOUSE,38805.5,8.8,2557,2557.1,27.31,27.31,NA,327,Tumor necrosis factor receptor superfamily member 6,extracellular region|nucleus|cytoplasm|plasma membrane|external side of plasma membrane|cell surface|integral component of membrane|death-inducing signaling complex|CD95 death-inducing signaling complex|membrane raft|extracellular exosome|,immunoglobulin production|renal system process|apoptotic process|activation-induced cell death of T cells|inflammatory cell apoptotic process|transformed cell apoptotic process|circadian rhythm|extrinsic apoptotic signaling pathway via death domain receptors|response to toxic substance|gene expression|B cell mediated immunity|positive regulation of protein homooligomerization|T cell homeostasis|positive regulation of apoptotic process|negative regulation of apoptotic process|negative thymic T cell selection|regulation of lymphocyte differentiation|regulation of myeloid cell differentiation|spleen development|negative regulation of B cell activation|protein homooligomerization|response to glucocorticoid|neuron apoptotic process|cellular response to mechanical stimulus|cellular response to lithium ion|cellular response to hyperoxia|positive regulation of release of cytochrome c from mitochondria|motor neuron apoptotic process|apoptotic signaling pathway|extrinsic apoptotic signaling pathway|extrinsic apoptotic signaling pathway in absence of ligand|hepatocyte apoptotic process|necroptotic signaling pathway|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand|,transmembrane signaling receptor activity|protein binding|kinase binding|identical protein binding|,2,3,3.50E+07,0.088,P25446,0.009135716,-0.0255,32.76904537,0.614333333,0.000528561,6.304551641,-0.444,-0.381,-0.173,0.293,0.231,0.321,undefined,6,TRUE,TRUE
2.2485,2.562,1.763,1.407,1.745,0.941,1.6595,2.0125,1.2095,P30204,P30204,Msr1,1,2,2,2,P30204|P30204-2,MOUSE,50739.3,6.1,2565,2565.1,27.06,27.06,NA,458,Macrophage scavenger receptor types I and II,collagen trimer|cytosol|plasma membrane|integral component of membrane|cytoplasmic vesicle|low-density lipoprotein particle|,receptor-mediated endocytosis|positive regulation of macrophage derived foam cell differentiation|positive regulation of cholesterol storage|cholesterol transport|plasma lipoprotein particle clearance|lipoprotein transport|cellular response to organic cyclic compound|,scavenger receptor activity|low-density lipoprotein particle binding|,2,2,4540000,0.061,P30204,0.004302626,-0.106333333,36.50910488,1.706666667,0.000223403,7.360576813,-0.996,-1.237,-0.646,1.163,0.399,0.679,undefined,9,NA,TRUE
0.3795,0.016,0.784,0.678,0.339,1.102,0.5925,0.2675,1.0325,Q3UTR7,Q3UTR7,Agt,1,2,2,2,Q3UTR7|P11859,MOUSE,52954.5,4.5,2576,2576.1,26.77,26.77,NA,482,Angiotensinogen,extracellular space|cytoplasm|extracellular exosome|blood microparticle|,"ovarian follicle rupture|blood vessel development|branching involved in ureteric bud morphogenesis|kidney development|regulation of systemic arterial blood pressure by circulatory renin-angiotensin|angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure|renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure|renin-angiotensin regulation of aldosterone production|regulation of renal output by angiotensin|regulation of heart rate|brain renin-angiotensin system|renal system process|angiotensin-mediated drinking behavior|positive regulation of extracellular matrix constituent secretion|cellular sodium ion homeostasis|cell-matrix adhesion|G-protein coupled receptor signaling pathway|activation of phospholipase C activity|activation of NF-kappaB-inducing kinase activity|female pregnancy|aging|excretion|establishment of blood-nerve barrier|regulation of blood pressure|negative regulation of cell proliferation|response to cold|response to salt stress|regulation of gene expression|positive regulation of activation of JAK2 kinase activity|positive regulation of endothelial cell migration|positive regulation of cardiac muscle hypertrophy|positive regulation of gene expression|positive regulation of cholesterol esterification|negative regulation of endopeptidase activity|regulation of norepinephrine secretion|positive regulation of phosphatidylinositol 3-kinase signaling|artery smooth muscle contraction|response to muscle activity involved in regulation of muscle adaptation|negative regulation of angiogenesis|extracellular matrix organization|negative regulation of cell growth|peristalsis|positive regulation of cellular protein metabolic process|positive regulation of superoxide anion generation|positive regulation of peptidyl-serine phosphorylation|negative regulation of tissue remodeling|catenin import into nucleus|positive regulation of renal sodium excretion|positive regulation of multicellular organism growth|vasodilation|hormone metabolic process|drinking behavior|regulation of apoptotic process|positive regulation of MAPK cascade|negative regulation of neuron apoptotic process|positive regulation of nitric oxide biosynthetic process|positive regulation of fatty acid biosynthetic process|positive regulation of epidermal growth factor receptor signaling pathway|positive regulation of transcription, DNA-templated|positive regulation of vasodilation|positive regulation of organ growth|astrocyte activation|fibroblast proliferation|positive regulation of fibroblast proliferation|regulation of long-term neuronal synaptic plasticity|smooth muscle cell proliferation|cytokine secretion|regulation of inflammatory response|positive regulation of peptidyl-tyrosine phosphorylation|smooth muscle cell differentiation|negative regulation of neurotrophin TRK receptor signaling pathway|stress-activated MAPK cascade|regulation of calcium ion transport|regulation of transmission of nerve impulse|cell growth involved in cardiac muscle cell development|positive regulation of protein tyrosine kinase activity|ERK1 and ERK2 cascade|uterine smooth muscle contraction|cellular response to mechanical stimulus|positive regulation of branching involved in ureteric bud morphogenesis|positive regulation of protein kinase C activity|regulation of extracellular matrix assembly|positive regulation of membrane hyperpolarization|positive regulation of gap junction assembly|regulation of cardiac conduction|positive regulation of extrinsic apoptotic signaling pathway|",serine-type endopeptidase inhibitor activity|hormone activity|sodium channel regulator activity|type 1 angiotensin receptor binding|type 2 angiotensin receptor binding|,2,2,1.22E+08,0.045,Q3UTR7,0.223662093,-0.142,14.62651093,0.609333333,0.034462669,2.668001365,-0.376,-0.035,-0.929,-0.021,0.287,0.222,PC,5,TRUE,NA
1.1155,1.355,0.827,0.524,0.78,-0.034,0.4945,0.6725,0.1325,P56391,P56391,Cox6b1,1,3,2,2,P56391|A0A140LIU3,MOUSE,10299.5,33.7,2599,2599.1,26.27,26.27,NA,86,Cytochrome c oxidase subunit 6B1,mitochondrion|mitochondrial inner membrane|mitochondrial intermembrane space|,substantia nigra development|hydrogen ion transmembrane transport|,cytochrome-c oxidase activity|,2,3,29300000,0.337,P56391,0.29188532,0.048333333,12.4775799,0.632,0.056525187,2.31672569,-0.376,-0.494,0.067,0.94,0.03,0.123,NC,5,NA,NA
1.0975,1.351,1.156,1.599,1.66,1.552,1.3785,1.5075,1.4805,P47877,P47877,Igfbp2,1,4,3,3,P47877|D3YU40,MOUSE,33930.2,10.1,2607,2607.1,26.02,26.02,NA,305,Insulin-like growth factor-binding protein 2,extracellular region|extracellular space|apical plasma membrane|cytoplasmic vesicle|extracellular exosome|,regulation of cell growth|signal transduction|female pregnancy|aging|response to nutrient|response to mechanical stimulus|response to lithium ion|response to estradiol|response to retinoic acid|cellular response to hormone stimulus|positive regulation of activated T cell proliferation|response to drug|regulation of insulin-like growth factor receptor signaling pathway|response to glucocorticoid|,insulin-like growth factor binding|insulin-like growth factor I binding|insulin-like growth factor II binding|,3,4,1.27E+09,0.101,P47877,0.000673572,-0.068,47.36659886,1.382,1.83E-05,11.12262546,-0.615,-0.847,-0.815,0.406,0.744,0.719,PC,9,TRUE,NA
-0.9165,0.961,1.617,-0.306,1.424,2.286,-1.5285,0.3425,1.1375,K7N6K8,K7N6K8,Sult2a7,1,7,3,3,A0A1B0GRF0|K7N6K8|A0A1B0GR21|A0A1B0GSJ3,MOUSE,34925.5,11.7,2652,2652.1,25,25,NA,298,Sulfotransferase,NA,metabolic process|,sulfotransferase activity|,3,7,2.49E+10,0.117,K7N6K8,0.744610746,-0.000833333,3.323613626,0.553,0.465198855,0.775816276,1.255,-0.5,-1.587,0.189,0.94,-0.302,undefined,5,NA,NA
1.7905,1.542,1.341,1.381,1.121,0.977,1.9435,1.8005,1.5695,B2KFW1,B2KFW1,Zscan20,1,7,4,4,B2KFW1|E9Q8Y3|E9PVW1|A0A1L1SU99,MOUSE,117658.8,5,2684,2684.1,24.29,24.29,NA,1030,Zinc finger and SCAN domain-containing protein 20,nucleoplasm|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",RNA polymerase II regulatory region sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity|metal ion binding|,4,7,4.03E+09,0.05,B2KFW1,0.00167657,-0.006166667,41.34269603,1.448333333,7.34E-05,8.870283244,-0.932,-0.643,-0.616,0.73,0.438,0.986,NC,9,NA,NA
1.1865,1.216,1.039,1.024,1.079,0.897,0.9215,0.9905,0.8095,Q61830,Q61830,Mrc1,1,4,3,3,Q61830,MOUSE,167944.9,1.7,2708,2708.1,23.79,23.79,NA,1456,Macrophage mannose receptor 1,plasma membrane|cell surface|endosome membrane|integral component of membrane|,receptor-mediated endocytosis|signal transduction|cellular response to lipopolysaccharide|cellular response to interferon-gamma|cellular response to interleukin-4|,receptor activity|transmembrane signaling receptor activity|mannose binding|,3,4,1.27E+08,0.017,Q61830,0.000456973,-0.047166667,49.78601176,1.011,1.05E-05,11.98535206,-0.561,-0.582,-0.515,0.559,0.449,0.367,undefined,9,TRUE,TRUE
2.9755,3.108,1.458,2.949,3.124,1.281,3.3905,3.5805,1.9235,P42703-2,P42703,Lifr,1,8,3,3,P42703-2|P42703,MOUSE,82255.7,4.7,2761,2761.1,22.6,22.6,NA,1092,Isoform 2 of Leukemia inhibitory factor receptor,plasma membrane|integral component of membrane|receptor complex|extracellular exosome|,positive regulation of cell proliferation|negative regulation of muscle cell apoptotic process|response to organic cyclic compound|cytokine-mediated signaling pathway|organ regeneration|response to cytokine|oncostatin-M-mediated signaling pathway|neuron projection morphogenesis|leukemia inhibitory factor signaling pathway|ciliary neurotrophic factor-mediated signaling pathway|,leukemia inhibitory factor receptor activity|ciliary neurotrophic factor receptor binding|protein binding|growth factor binding|cytokine binding|protein heterodimerization activity|ciliary neurotrophic factor receptor activity|oncostatin-M receptor activity|,3,8,7.04E+09,0.047,P42703-2,0.003240647,-0.346833333,37.84062298,2.733,0.000164414,7.753156653,-2.112,-2.127,-0.901,0.88,0.823,1.356,PC,9,TRUE,TRUE
0.8355,0.849,0.641,0.545,0.62,0.407,1.0155,1.1355,0.9905,P06683,P06683,C9,1,3,2,2,A0A0R4J032|P06683,MOUSE,63256.4,4.5,2791,2791.1,21.84,21.84,NA,548,Complement component C9,membrane attack complex|cytoplasm|plasma membrane|extracellular exosome|blood microparticle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",NA,2,3,2.59E+08,0.045,P06683,0.013927977,0.080666667,30.38711916,0.792666667,0.00091472,5.752474055,-0.369,-0.383,-0.195,0.46,0.246,0.725,PC,6,TRUE,NA
1.0775,1.326,1.839,1.04,1.313,1.821,0.8715,1.2035,1.6795,Q9QZ25,Q9QZ25,Vnn3,1,4,2,2,Q9QZ25,MOUSE,56931.6,5.4,2817,2817.1,21.31,21.31,NA,500,Vascular non-inflammatory molecule 3,extracellular space|plasma membrane|anchored component of membrane|,pantothenate metabolic process|,pantetheine hydrolase activity|,2,4,6.34E+08,0.054,Q9QZ25,0.016345732,-0.223833333,29.4924536,1.395,0.00112397,5.541537687,-0.504,-0.741,-1.519,0.485,0.517,0.419,PC,9,TRUE,NA
0.2885,0.133,0.369,0.973,0.935,1.166,0.9365,1.1245,1.4855,P06745,P06745,Gpi,1,3,2,2,P06745,MOUSE,62994,4.1,2841,2841.1,20.91,20.91,NA,558,Glucose-6-phosphate isomerase,extracellular space|nucleoplasm|cytoplasm|plasma membrane|membrane|myelin sheath|ciliary membrane|extracellular exosome|,angiogenesis|in utero embryonic development|mesoderm formation|gluconeogenesis|glycolytic process|erythrocyte homeostasis|glucose homeostasis|glycolytic process through glucose-6-phosphate|,glucose-6-phosphate isomerase activity|cytokine activity|protein binding|growth factor activity|,2,3,1.60E+08,0.041,P06745,0.117607035,0.192,18.8149945,0.842,0.013137132,3.383368296,-0.161,-0.112,-0.414,0.045,0.801,0.993,PC,6,NA,NA
0.9605,0.844,0.792,0.903,0.811,0.753,0.9585,0.8815,0.8255,Q5SV85,Q5SV85,Synrg,1,2,2,2,V9GX40|Q5SV85|V9GXD9|Q5SV85-2,MOUSE,140526.3,2.3,2842,2842.1,20.87,20.87,NA,1306,Synergin gamma,Golgi apparatus|cytosol|membrane|,endocytosis|protein transport|,NA,2,2,41900000,0.023,Q5SV85,0.000646237,-0.069166667,47.63700368,0.859666667,1.72E-05,11.07888578,-0.561,-0.447,-0.489,0.349,0.326,0.407,undefined,9,NA,NA
2.7535,2.646,2.29,3.113,3.03,2.571,2.9915,2.8275,2.3415,Q9EPR2,Q9EPR2,Pla2g12a,1,4,2,2,Q9EPR2|Q9EPR2-2,MOUSE,22117.7,11.4,2847,2847.1,20.6,20.6,NA,192,Group XIIA secretory phospholipase A2,extracellular region|intracellular|endoplasmic reticulum|Golgi apparatus|,phospholipid metabolic process|lipid catabolic process|,phospholipase A2 activity|calcium ion binding|,2,4,1.96E+08,0.114,Q9EPR2,5.51E-05,-0.453,68.40477047,2.749333333,1.44E-07,23.88934723,-1.929,-1.764,-1.79,0.729,1.088,0.948,PC,9,TRUE,NA
0.9355,0.737,0.355,0.67,0.497,0.109,0.9905,0.8315,0.4455,Q91W18,Q91W18,Tdrd3,1,2,2,2,Q91W18|Q91W18-3|Q91W18-2,MOUSE,82650.7,4.5,2867,2867.1,20.17,20.17,NA,743,Tudor domain-containing protein 3,nucleus|cytoplasm|exon-exon junction complex|,mRNA processing|chromatin modification|regulation of nucleic acid-templated transcription|,chromatin binding|transcription coactivator activity|methylated histone binding|poly(A) RNA binding|,2,2,22400000,0.045,Q91W18,0.082545664,0.06,20.88007632,0.611333333,0.00816568,3.757530709,-0.487,-0.294,0.044,0.416,0.165,0.516,undefined,5,NA,NA
1.7605,2.585,1.977,-0.645,-0.574,-0.393,1.8815,2.7455,2.1335,Q19LI2,Q19LI2,A1bg,1,3,2,2,Q19LI2,MOUSE,57237.7,3.3,2873,2873.1,20.05,20.05,NA,512,Alpha-1B-glycoprotein,extracellular region|extracellular space|extracellular exosome|blood microparticle|,NA,NA,2,3,1.90E+08,0.033,Q19LI2,0.374885902,0.343833333,10.29793931,1.323666667,0.093369723,1.965379729,0.037,-0.692,-0.299,1.703,-0.641,1.955,PC,6,TRUE,NA
1.7905,1.542,1.403,1.381,1.121,1.017,1.9435,1.8005,1.8135,I7HPW8,I7HPW8,Myo15b,1,5,3,3,I7HPW8,MOUSE,335247.9,1.1,2879,2879.1,19.93,19.93,NA,3033,Myosin XVB,brush border|myosin complex|,metabolic process|,motor activity|ATP binding|,3,5,2.31E+09,0.011,I7HPW8,0.001458916,-0.033166667,42.17912151,1.542333333,6.05E-05,9.156623132,-0.932,-0.643,-0.838,0.73,0.438,1.046,undefined,9,NA,NA
0.4175,0.579,0.71,0.316,0.502,0.628,0.3635,0.5645,0.6915,Q3TGW2,Q3TGW2,Eepd1,1,2,2,2,Q3TGW2,MOUSE,63465.8,4.5,2881,2881.1,19.93,19.93,NA,569,Endonuclease/exonuclease/phosphatase family domain-containing protein 1,NA,DNA repair|,DNA binding|,2,2,9.80E+07,0.045,Q3TGW2,0.035304239,-0.072,25.50670634,0.529333333,0.002814034,4.66227583,-0.156,-0.314,-0.54,0.214,0.146,0.218,undefined,5,NA,NA
0.9415,0.927,1.464,0.286,0.296,0.828,0.6785,0.7045,1.2365,Q91Y47,Q91Y47,F11,1,2,2,2,Q91Y47,MOUSE,71784.4,6.2,2884,2884.1,19.9,19.9,NA,624,Coagulation factor XI,extracellular space|extracellular exosome|,blood coagulation|regulation of blood coagulation|plasminogen activation|positive regulation of fibrinolysis|,serine-type endopeptidase activity|heparin binding|,2,2,90300000,0.062,Q91Y47,0.105773062,0.055166667,19.51099394,0.836333333,0.011191817,3.507635512,-0.142,-0.125,-0.822,0.734,0.134,0.552,PC,7,TRUE,NA
0.6885,1.01,0.911,0.22,0.567,0.463,0.2305,0.5925,0.4895,A2A8R7,A2A8R7,Zcchc11,1,2,2,2,A2A8R7|B2R4,MOUSE,187918.5,1.9,2945,2945.1,18.68,18.68,NA,1648,Terminal uridylyltransferase 4,extracellular space|nucleus|nucleolus|cytoplasm|extracellular exosome|,cytokine production|miRNA catabolic process|stem cell maintenance|pre-miRNA processing|RNA 3'-end processing|regulation of lipopolysaccharide-mediated signaling pathway|negative regulation of NF-kappaB transcription factor activity|,protein binding|zinc ion binding|poly(A) RNA binding|RNA uridylyltransferase activity|,2,2,39600000,0.019,A2A8R7,0.082811075,0.005166667,20.83499045,0.559666667,0.008250893,3.749179946,-0.072,-0.375,-0.377,0.552,0.134,0.169,undefined,5,NA,NA
1.1845,1.139,1.01,2.04,1.993,1.86,1.5455,1.5135,1.3805,E9Q309,E9Q309,Cep350,1,5,3,3,E9Q309|Q8VI16,MOUSE,348504.1,0.6,2948,2948.1,18.64,18.64,NA,3095,Centrosome-associated protein 350,nucleoplasm|cytoplasm|centrosome|membrane|,microtubule anchoring|,microtubule binding|,3,5,6.63E+08,0.006,E9Q309,0.005206365,0.085,35.58819441,1.503333333,0.000276173,7.098653947,-0.68,-0.66,-0.66,0.411,1.291,0.808,NC,9,NA,NA
0.6315,0.47,0.583,0.685,0.548,0.656,0.6825,0.5595,0.6685,Q9ERV1,Q9ERV1,Mkrn2,1,2,2,2,Q9ERV1,MOUSE,47965.3,4.8,2958,2958.1,18.5,18.5,NA,416,Probable E3 ubiquitin-protein ligase makorin-2,intracellular|,protein ubiquitination|,zinc ion binding|ligase activity|poly(A) RNA binding|,2,2,41400000,0.048,Q9ERV1,0.005181993,-5.00E-04,35.63161156,0.612333333,0.000273425,7.043281975,-0.345,-0.193,-0.382,0.248,0.324,0.345,undefined,6,NA,NA
0.6055,0.747,0.937,0.321,0.645,0.829,0.4225,0.6775,0.8625,Q62087,Q62087,Pon3,1,3,2,2,Q62087,MOUSE,39578.7,7,3002,3002.1,17.88,17.88,NA,354,Serum paraoxonase/lactonase 3,extracellular space|intracellular membrane-bounded organelle|extracellular exosome|,phenylacetate catabolic process|dephosphorylation|aromatic compound catabolic process|negative regulation of superoxide anion generation|coumarin catabolic process|carboxylic acid catabolic process|,"aryldialkylphosphatase activity|arylesterase activity|3,4-dihydrocoumarin hydrolase activity|protein homodimerization activity|metal ion binding|dihydrocoumarin hydrolase activity|",2,3,70300000,0.07,Q62087,0.043640182,-0.150333333,24.34808013,0.743333333,0.003674447,4.427609524,-0.211,-0.521,-0.834,0.349,0.094,0.221,PC,7,TRUE,NA
1.1465,1.278,1.534,1.115,1.342,1.561,1.2955,1.5365,1.7575,A0A087WQ44,A0A087WQ44,Srcap,1,9,3,3,A0A087WQ44|A0A087WNL7|A0A087WNX7|A0A087WP63,MOUSE,351143.1,0.7,3014,3014.1,17.58,17.58,NA,3271,Snf2-related CREBBP activator protein,nucleus|nucleoplasm|Golgi apparatus|protein complex|perinuclear region of cytoplasm|,NA,DNA binding|ATP binding|,3,9,5.98E+09,0.007,A0A087WQ44,0.002633628,-0.1505,38.83288097,1.394333333,0.000130831,8.056850022,-0.585,-0.767,-1.191,0.421,0.494,0.725,undefined,9,NA,NA
0.9935,1.534,1.59,-0.326,0.276,0.954,-0.7375,-0.1905,0.7175,E9Q4F8,E9Q4F8,Ankrd11,1,5,3,3,E9Q4F8|E9Q4F7,MOUSE,300682.4,1.5,3036,3036.1,17.23,17.23,NA,2664,Ankyrin repeat domain-containing protein 11,nucleus|nucleoplasm|cytoplasm|plasma membrane|,in utero embryonic development|tissue homeostasis|multicellular organism growth|odontogenesis of dentin-containing tooth|skeletal system morphogenesis|head morphogenesis|face morphogenesis|bone development|,NA,3,5,1.61E+09,0.015,E9Q4F8,0.596804892,-0.012166667,5.514503855,0.618333333,0.280898626,1.176134838,0.345,-0.114,-1.195,1.215,0.09,-0.414,undefined,5,NA,NA
1.3445,1.143,1.278,0.973,0.795,0.925,1.4435,1.2815,1.4125,A2AS37,A2AS37,AI182371,1,2,2,2,A2AS37,MOUSE,40887.3,5.8,3055,3055.1,16.93,16.93,NA,356,Expressed sequence AI182371,extracellular region|,inflammatory response|complement activation|negative regulation of endopeptidase activity|,endopeptidase inhibitor activity|,2,2,17700000,0.058,A2AS37,0.002693809,0.004166667,38.71028979,1.185666667,0.000134577,8.018799132,-0.636,-0.435,-0.695,0.641,0.325,0.825,undefined,9,TRUE,NA
0.8185,0.733,1.177,0.366,0.412,0.83,0.4565,0.5565,0.8515,Q8BWS5,Q8BWS5,Gprin3,1,3,2,2,Q8BWS5,MOUSE,81396,3.8,3066,3066.1,16.72,16.72,NA,763,G protein-regulated inducer of neurite outgrowth 3,NA,NA,NA,2,3,11700000,0.038,Q8BWS5,0.082545664,-0.0405,20.87346852,0.674333333,0.008178114,3.756306284,-0.188,-0.205,-0.74,0.509,0.166,0.215,undefined,6,NA,NA
2.6395,3.357,2.811,3.06,3.801,3.299,2.8005,3.5565,3.1685,A2ARZ3,A2ARZ3,Fsip2,1,8,2,2,A2ARZ3,MOUSE,790434.4,0.3,3074,3074.1,16.63,16.63,NA,6995,Fibrous sheath-interacting protein 2,mitochondrion|motile cilium|,NA,protein binding|,2,8,1.59E+10,0.003,A2ARZ3,0.000181344,-0.539,57.61832927,3.17,1.73E-06,16.19505956,-1.787,-2.361,-2.224,0.748,1.273,1.117,undefined,9,NA,NA
2.1845,1.818,2.509,2.183,1.841,2.527,2.3075,1.9815,2.6685,Q9QX60,Q9QX60,Dguok,1,2,2,2,Q9QX60|Q504N4|Q9QX60-2,MOUSE,32394.5,17.3,3086,3086.1,16.48,16.48,NA,277,"Deoxyguanosine kinase, mitochondrial",nucleus|cytoplasm|mitochondrion|cytosol|,nucleobase-containing compound metabolic process|protein phosphorylation|deoxyribonucleoside monophosphate biosynthetic process|nucleotide biosynthetic process|negative regulation of neuron projection development|dGTP metabolic process|purine deoxyribonucleoside metabolic process|,deoxyguanosine kinase activity|ATP binding|nucleoside kinase activity|,2,2,10500000,0.173,B2RQG2,0.791109747,-0.133833333,2.639015298,0.197,0.544626125,0.639149483,0.342,-0.095,-0.944,-0.08,0.083,-0.109,NC,9,NA,NA
0.8495,0.856,0.41,0.504,0.536,0.084,0.5875,0.6335,0.1835,Q3UMY5,Q3UMY5,Eml4,1,3,2,2,Q3UMY5|F8WJ93|Q3UMY5-3|Q3UMY5-2|A0A0R4J1G7|Q3UMY5-4|A0A0R4J0H0,MOUSE,111108.9,3.4,3114,3114.1,16,16,NA,988,Echinoderm microtubule-associated protein-like 4,cytoplasm|microtubule|membrane|microtubule cytoskeleton|mitotic spindle|,negative regulation of microtubule depolymerization|,NA,2,3,87700000,0.034,E9QM38,0.053627933,-0.147,23.25495113,0.935333333,0.004726122,4.210174442,-1.114,-0.365,-0.365,0.505,0.29,0.167,NC,5,NA,NA
1.1715,0.982,0.308,1.114,0.949,0.27,1.2865,1.1365,0.4595,Q9DBZ1,Q9DBZ1,Ikbip,1,2,2,2,Q9DBZ1|E9QMH7|Q9DBZ1-2,MOUSE,42588.3,6.7,3118,3118.1,15.91,15.91,NA,373,Inhibitor of nuclear factor kappa-B kinase-interacting protein,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|,NA,NA,2,2,1.13E+09,0.067,Q8BPB5,0.046152071,0.016,24.09058128,0.686666667,0.003898898,4.375840169,-0.212,-0.357,-0.413,0.165,0.218,0.695,undefined,6,NA,NA
1.1855,0.856,1.107,1.748,1.443,1.688,1.6485,1.3585,1.6045,O08599-2,O08599,Stxbp1,1,2,2,2,O08599-2|O08599,MOUSE,69134.1,4.1,3181,3181.1,15.06,15.06,NA,594,Isoform 2 of Syntaxin-binding protein 1,nucleoplasm|cytoplasm|mitochondrion|cytosol|plasma membrane|platelet alpha granule|terminal bouton|myelin sheath|protein complex|extracellular exosome|,"platelet degranulation|exocytosis|vesicle docking involved in exocytosis|neurotransmitter secretion|neuromuscular synaptic transmission|axon target recognition|regulation of synaptic vesicle priming|protein transport|synaptic vesicle maturation|synaptic vesicle fusion to presynaptic membrane|negative regulation of synaptic transmission, GABAergic|negative regulation of neuron apoptotic process|positive regulation of calcium ion-dependent exocytosis|protein stabilization|long term synaptic depression|platelet aggregation|protein localization to plasma membrane|",protein binding|syntaxin-1 binding|protein kinase binding|protein domain specific binding|syntaxin binding|identical protein binding|poly(A) RNA binding|protein N-terminus binding|,2,2,6.25E+08,0.041,Q6PAL7,0.685720132,-0.022,4.069883558,0.108666667,0.391752381,0.91743482,-0.127,-0.195,0.093,0.115,-0.138,0.12,undefined,9,NA,NA
0.8995,0.688,1.036,0.439,0.508,0.851,0.2355,0.3805,0.8135,Q62240,Q62240,Kdm5d,1,6,3,3,Q62240|Q62240-2|Q62240-4|Q62240-3|Q8BQM3,MOUSE,179924.3,2.5,3186,3186.1,15.01,15.01,NA,1548,Lysine-specific demethylase 5D,nucleus|,histone H3-K4 demethylation|oxidation-reduction process|,"DNA binding|zinc ion binding|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors|histone demethylase activity (H3-K4 specific)|",3,6,8.95E+08,0.025,Q61464,0.362516229,-0.0455,10.67692373,0.244333333,0.08556726,2.02636056,0.003,-0.099,-0.407,0.056,0.055,0.119,undefined,6,NA,NA
0.7925,1.062,0.857,0.504,0.798,0.602,0.9915,1.3005,0.6435,P98064-2,P98064,Masp1,1,3,2,2,P98064-2|P98064,MOUSE,83984.9,4.3,3217,3217.1,14.47,14.47,NA,704,Isoform 2 of Mannan-binding lectin serine protease 1,extracellular space|,"complement activation, lectin pathway|proteolysis|",serine-type endopeptidase activity|calcium ion binding|protein homodimerization activity|calcium-dependent protein binding|,2,3,74700000,0.043,Q9WV54,0.000713816,-0.2205,46.72923965,1.672333333,2.12E-05,10.86219019,-0.818,-1.368,-0.984,0.74,0.536,0.571,PC,7,TRUE,NA
0.7785,0.95,-0.465,0.841,1.038,-0.589,1.7235,1.6735,0.4935,Q1ERP8,Q1ERP8,Cd300lg,1,8,2,2,Q1ERP8|Q1ERP8-3|Q1ERP8-2|Q1ERP8-5,MOUSE,37212,6.6,3328,3328.1,13.17,13.17,NA,331,CMRF35-like molecule 9,integral component of membrane|basolateral plasma membrane|apical plasma membrane|multivesicular body membrane|extracellular exosome|,immune system process|immunoglobulin transcytosis in epithelial cells|,IgM binding|,2,8,1.06E+09,0.066,P54728,0.856898635,0.017666667,1.797116315,0.199333333,0.66113229,0.459125113,-0.441,-0.724,0.919,-0.016,-0.145,0.513,undefined,6,TRUE,TRUE
1.5075,2.3,3.601,-0.278,0.485,1.74,-0.4975,0.3435,1.6245,Q8BGR5,Q8BGR5,Fam53b,1,7,2,2,Q8BGR5|Q8BGR5-2,MOUSE,47250.6,3.5,3351,3351.1,12.92,12.92,NA,422,Protein FAM53B,NA,NA,NA,2,7,3.84E+08,0.035,Q9QZZ4,0.875324243,-0.078,1.554306046,0.139333333,0.699148444,0.404072605,0.281,0.135,-0.859,-0.419,0.405,-0.011,undefined,5,NA,NA
0.5135,1.068,0.62,0.613,1.192,0.739,0.5115,1.1045,0.6525,Q60674,Q60674,Nr1d2,1,2,2,2,Q60674|Q3UV55,MOUSE,65384.8,2.9,3362,3362.1,12.79,12.79,NA,576,Nuclear receptor subfamily 1 group D member 2,nucleus|,"transcription, DNA-templated|regulation of transcription, DNA-templated|regulation of lipid metabolic process|intracellular receptor signaling pathway|regulation of circadian rhythm|steroid hormone mediated signaling pathway|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|rhythmic process|regulation of inflammatory response|lipid homeostasis|regulation of energy homeostasis|regulation of skeletal muscle cell differentiation|",core promoter sequence-specific DNA binding|DNA binding|sequence-specific DNA binding transcription factor activity|steroid hormone receptor activity|thyroid hormone receptor activity|protein binding|zinc ion binding|,2,2,3.77E+09,0.029,Q8BP71,0.330893405,0.013,11.5087539,-0.252666667,0.070652024,-2.160268617,0.03,0.273,0.115,-0.217,-0.201,0.078,undefined,6,NA,NA
2.9645,3.074,3.764,0.185,0.318,1.003,0.0245,0.1725,0.8595,Q70KF4,Q70KF4,Cmya5,1,3,2,2,Q70KF4|E9QLJ0|Q5SXY1|A0A0J9YTU3|Q5SXY1-3|A0A0J9YUR2|Q5SXY1-2|A0A0J9YUF8|A0A0J9YV86,MOUSE,414573.2,0.3,3414,3414.1,12.38,12.38,NA,3739,Cardiomyopathy-associated protein 5,M band|costamere|perinuclear region of cytoplasm|,regulation of skeletal muscle adaptation|negative regulation of protein phosphatase type 2B activity|negative regulation of calcineurin-NFAT signaling cascade|,protein binding|identical protein binding|,2,3,1.32E+09,0.003,A0A087WNW2,0.01439753,-0.0935,30.20301861,-0.695,0.000954329,-5.708612121,0.218,0.29,0.254,-0.524,-0.604,-0.195,undefined,5,NA,NA
0.7495,0.799,1.147,1.048,1.122,1.465,0.9325,1.0215,1.3645,Q91XL9,Q91XL9,Osbpl1a,1,2,2,2,Q91XL9|Q3V156|Q91XL9-2|Q91XL9-3|Q8K2D2,MOUSE,109276.6,3.3,3427,3427.1,12.29,12.29,NA,950,Oxysterol-binding protein-related protein 1,nucleus|nucleoplasm|cytoplasm|late endosome|extracellular exosome|,lipid transport|,protein binding|cholesterol binding|,2,2,30700000,0.033,P70289,0.514131936,-0.188166667,7.033871292,0.345,0.197976148,1.433989191,-0.124,-0.056,-0.902,0.205,-0.109,-0.143,undefined,9,NA,NA
1.6225,1.198,2.778,0.486,0.085,1.661,1.6075,1.2225,2.7995,Q6PHN1,Q6PHN1,Ccdc57,1,2,2,2,Q6PHN1,MOUSE,116762.4,2.7,3441,3441.1,12.15,12.15,NA,1016,Coiled-coil domain-containing protein 57,NA,NA,NA,2,2,7.90E+08,0.027,Q8CI61,0.247199394,-0.018833333,13.87916409,0.395,0.040933944,2.544974111,-0.072,-0.447,-0.13,-0.058,0.194,0.4,undefined,7,NA,NA
1.1935,1.654,0.556,0.35,0.835,-0.268,0.7015,1.2015,0.0995,P70194,P70194,Clec4f,1,3,2,2,P70194|A0A0R4IZZ5,MOUSE,61667,4.5,3471,3471.1,11.81,11.81,NA,548,C-type lectin domain family 4 member F,plasma membrane|integral component of membrane|,endocytosis|NK T cell activation|,galactose binding|glycolipid binding|,2,3,1.08E+08,0.045,Q5SS00,0.813557391,-0.024833333,2.276981272,-0.071666667,0.591972964,-0.563590823,0.122,0.097,-0.186,-0.153,0.124,-0.153,undefined,5,NA,TRUE
0.7265,0.635,0.907,0.763,0.697,0.964,0.8115,0.7595,1.0275,Q91WR3-3,Q91WR3,Ascc2,1,2,2,2,Q91WR3-3|Q91WR3|Q91WR3-2,MOUSE,88681.3,5,3486,3486.1,11.64,11.64,NA,749,Isoform 3 of Activating signal cointegrator 1 complex subunit 2,NA,"transcription, DNA-templated|regulation of transcription, DNA-templated|",NA,2,2,5.23E+08,0.05,E9PZQ0,0.797440902,0.11,2.504433309,-0.172,0.561767576,-0.61135676,-0.179,-0.077,0.844,-0.055,-0.134,0.261,NC,9,NA,NA
0.5785,0.752,1.321,0.799,0.997,1.561,0.5225,0.7355,1.3005,Q8BZ05,Q8BZ05,Arap2,1,2,2,2,Q8BZ05|E9QP44,MOUSE,195620.1,1.8,3521,3521.1,11.33,11.33,NA,1703,"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2",cytoplasm|,signal transduction|positive regulation of GTPase activity|,"GTPase activator activity|phosphatidylinositol-3,4,5-trisphosphate binding|metal ion binding|",2,2,2.91E+08,0.018,Q99JH8,0.488078859,0.047333333,7.540905802,-0.362666667,0.176160859,-1.517951796,-0.228,0.189,0.725,-0.309,-0.098,0.005,undefined,8,NA,NA
1.3805,1.644,1.437,0.99,1.278,1.066,1.1445,1.4475,1.2365,E9QPR5,E9QPR5,Ppp4r1,1,2,2,2,E9QPR5|Q8K2V1|E9PX53|Q8K2V1-2|E0CXK8,MOUSE,107977.8,2.7,3562,3562.1,11.06,11.06,NA,951,Serine/threonine-protein phosphatase 4 regulatory subunit 1,protein phosphatase 4 complex|,signal transduction|regulation of catalytic activity|,protein phosphatase type 4 regulator activity|,2,2,4.73E+08,0.027,D3YZ21,0.147299196,0.035666667,17.45126191,-0.503333333,0.017983483,-3.144787189,0.31,0.446,0.106,-0.116,-0.519,-0.013,undefined,9,NA,NA
2.0005,1.62,3.539,-0.299,-0.655,1.258,0.2245,-0.1165,1.7985,Q6NVD9,Q6NVD9,Bfsp2,1,5,2,2,Q6NVD9,MOUSE,45853.2,6.2,3587,3587.1,10.83,10.83,NA,416,Phakinin,cytoplasm|intermediate filament|plasma membrane|,cytoskeleton organization|visual perception|intermediate filament cytoskeleton organization|cell maturation|response to stimulus|lens fiber cell development|,structural constituent of eye lens|protein binding|,2,5,1.30E+08,0.062,Q6PFX7,0.609699791,-0.056833333,5.311713296,-0.252333333,0.294326029,-1.140781966,-0.293,-0.004,0.505,-0.394,-0.21,0.055,NC,5,NA,NA
1.9825,1.838,2.9,-0.136,-0.256,0.802,0.4265,0.3215,1.3805,Q8R322,Q8R322,Gle1,1,2,2,2,Q8R322,MOUSE,80029.4,3.5,3591,3591.1,10.78,10.78,NA,699,Nucleoporin GLE1,extracellular space|nuclear pore|cytoplasm|plasma membrane|membrane|,protein transport|poly(A)+ mRNA export from nucleus|,identical protein binding|,2,2,2.64E+08,0.035,H9H9S8,0.937522058,0.104833333,0.789120888,0.066333333,0.833849958,0.2183717,-0.332,-0.168,0.715,0.102,-0.171,0.483,undefined,5,NA,NA